The scan is carried out in the first trimester, within a window described as 11 to 14 weeks of pregnancy, and the image is captured to defined measurement standards 1. A larger than expected number widens the conversation rather than ending it, and what follows is chosen with your clinical team. This page explains what the measurement is, which blood tests sit beside it, what a result can and cannot tell you, and when to get help quickly.
A number above the expected range for a given stage of pregnancy can reflect several different things, and on its own it names none of them. The fluid space is present in every fetus and changes as the fetus grows, so the figure is read against crown-rump length rather than as a fixed number 2. That is why two pregnancies with the same millimetre reading can sit in very different places once dates and image quality are taken into account.
Several different factors sit behind a larger reading.
Research suggests that outcomes after an early increased measurement vary widely, spanning chromosomal differences, structural differences and normal outcomes 5. That range is the reason a single number is never the end of the story.
The order that keeps this manageable is straightforward. The scan records an observation, the observation shifts a chance estimate, and the clinician who ordered the scan decides what is worth doing next. Nothing about the measurement is self-interpreting, and nothing about it belongs to you to interpret alone.
Two maternal serum markers are read with the scan in combined first-trimester screening, PAPP-A and free beta-hCG, and a separate blood test that looks at cell-free DNA may also be offered 6. All three are blood draws from the pregnant person. None of them samples the fetus directly.
| Marker | Why it belongs with this scan | What a result can and cannot tell you |
|---|---|---|
| PAPP-A (pregnancy-associated plasma protein A) | A placental protein measured in maternal blood as part of combined first-trimester screening 6. | It feeds into a chance estimate once it is read with the scan and your confirmed dates. It cannot name a condition on its own, and a single value read apart from the scan says little. |
| Free beta-hCG | A placental hormone fraction used in the same combined calculation 6. | It moves the chance estimate up or down. It describes probability across a population, not a result for one fetus, and it is not a diagnostic test. |
| Cell-free DNA (cfDNA) | Placental DNA circulating in maternal blood, screened for selected chromosomal conditions 6. | It gives screening-level information for the conditions it covers. Research suggests that a low-risk cfDNA result does not settle the picture when the scan measurement is increased 7. |
Serum values are read as printed on your lab report, in the units and multiples of the median your laboratory uses, and interpreted by your OB or midwife alongside the scan. These are pregnancy screening analytes rather than general-health markers, so reference points from non-pregnant testing do not apply to them.
Not in this setting, because PAPP-A is only meaningful here as one input into a combined estimate. It is a protein produced by the placenta and measured in a maternal blood sample, and in first-trimester screening it is reported alongside the scan rather than as a standalone result 6.
Studies suggest that first-trimester risk assessment performs better when the scan measurement and maternal serum markers are read together than when either part is read alone 3. That is the whole logic of combined screening. The scan contributes one piece of information, the blood contributes another, and the laboratory calculation blends them with your age and your dates.
Several things other than the fetus itself move a PAPP-A result. Accurate gestational dating matters, because the expected value shifts across the window. Maternal weight is factored in by the laboratory. A twin or higher-order pregnancy changes interpretation. Assisted conception and the specific laboratory platform can also shift where a value sits. This is why the report arrives adjusted rather than raw, and why a number copied from one laboratory does not transfer cleanly to another.
If your PAPP-A sits outside the range printed on your report, that is a point to raise with your OB or midwife promptly. They decide what it reflects in the context of your pregnancy and what, if anything, is worth adding.
Free beta-hCG adds the second serum input to the combined first-trimester calculation, and it is read with PAPP-A rather than against it 6. It is a fraction of human chorionic gonadotropin, the hormone produced by the placenta, measured from the same blood draw.
The laboratory does not report a verdict. It reports a probability, expressed as a chance figure, and that figure is handed to the clinician who ordered it.
The same practical factors apply. Dating accuracy, maternal weight, multiple pregnancy and the laboratory method all affect where a free beta-hCG value lands, which is why the adjusted result on your report is the number that counts. A value outside the printed range is worth discussing with your OB or midwife, who decides what it reflects and whether anything follows from it.
Cell-free DNA testing is a separate maternal blood screen rather than part of the combined calculation, and it screens for a selected group of chromosomal conditions 6. It works on fragments of placental DNA circulating in the pregnant person's bloodstream, which is why it needs only a blood draw.
Its place next to the scan is specific and worth understanding clearly. Research suggests that an increased nuchal measurement raises questions that a low-risk cell-free DNA result does not answer, because the scan finding can point toward differences that this blood screen does not cover 7. A reassuring cfDNA report and an increased measurement can sit side by side in the same pregnancy, and the combination is worked through with the clinical team rather than filed away.
Cell-free DNA screening has other limits worth knowing. It screens, it does not diagnose, so a high-chance result is confirmed with diagnostic testing that your OB or midwife discusses with you. Some samples return no result at all and need a repeat draw. And the conditions it covers are a defined list, not the full range of genetic variation.
A normal measurement and normal blood markers lower a chance estimate without ruling everything out, because first-trimester screening targets a limited set of conditions. That is a design feature of screening, not a flaw in your particular test.
There is also the reverse situation. Research suggests that outcomes after an early increased measurement cover a wide spread, so an increased number does not fix the path ahead any more than a normal number closes it 5. Screening narrows uncertainty. It does not remove it, and no honest reading of a report pretends otherwise.
The practical consequence is simple. Keep your later appointments even when the first-trimester report reads well, and ask your OB or midwife which parts of your pregnancy care are designed to pick up what this scan does not.
Certain signs in pregnancy need emergency assessment rather than a scheduled appointment, whatever your screening results said.
Call 911 or go to the emergency department for any of the following.
Contact your OB or midwife the same day for these signs.
A scan or blood value outside the range printed on your report is worth discussing with your OB or midwife promptly. They decide what it reflects, and they decide what comes next.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
First-trimester screening is ordered through pregnancy care, so the scan appointment and the blood draw that goes with it are arranged by your OB or midwife, and the report is read with them. Ask which screening options are offered in your care, whether the serum markers and the scan are scheduled together, and how the result will be explained to you. Treatment decisions belong to a licensed provider who has reviewed your pregnancy.
Outside pregnancy screening, FitScript is a labs-first health membership built around biomarker testing, with 150+ biomarkers tested per year, and Atlas, the AI health advisor inside the membership, explains what each result means in plain language. Prenatal screening analytes are not part of a general-health panel, so they stay with your OB or midwife.
This page is educational and is not medical advice.
For a general-health baseline outside pregnancy screening, the FitScript Essential panel is the broad starting point, while first-trimester screening itself stays with your OB or midwife.
Nuchal translucency is the fluid-filled space at the back of a developing baby's neck, visible on ultrasound in the first trimester. Every fetus has one. Sonographers measure its thickness and read it against the baby's size, and the figure feeds into a chance estimate that your OB or midwife explains.
A nuchal translucency ultrasound is a first-trimester scan done through the abdomen or internally, depending on image quality. The sonographer confirms your dates, checks the baby's position, then measures the fluid space at the neck with calipers. Ask the sonographer when your OB or midwife will have the report.
The nuchal translucency test reports a measurement in millimetres, which is combined with your dates, your age and two blood markers to produce a chance estimate for selected chromosomal conditions. It reports probability rather than a diagnosis, and your OB or midwife decides what the figure means for your care.
An increased measurement does not name a condition. It is a screening finding that shifts a chance estimate, and it is a reason to talk with your OB or midwife about what could come next. That conversation may cover a blood screen, diagnostic testing or a closer look at the baby's heart.
Scan preparations are minimal, though some clinics ask you to arrive with a full bladder. Wear clothing that gives easy access to your abdomen and bring your pregnancy records. Ask your OB or midwife in advance whether the blood draw for the serum markers happens at the same appointment.
Both routes are used. The sonographer starts on the abdomen and may suggest a transvaginal approach when the image is not clear enough for an accurate measurement, which can depend on the baby's position. Either way the measurement standard is the same, and your OB or midwife reads the report.
Your OB or midwife talks you through the options available in your care. Those can include a cell-free DNA blood screen, diagnostic testing such as chorionic villus sampling or amniocentesis, a detailed anatomy scan later in pregnancy, and a dedicated look at the baby's heart. You decide together.
Yes. Each fetus is measured separately and the report notes which measurement belongs to which. Interpretation differs from a single pregnancy because serum markers are read differently in multiples, so the combined estimate is handled by your OB or midwife, who explains which screening options apply to you.